Parenti Mariana, Melough Melissa M, Lapehn Samantha, MacDonald James, Bammler Theo, Firsick Evan J, Choi Hyo Young, Derefinko Karen J, Enquobahrie Daniel A, Carroll Kecia N, LeWinn Kaja Z, Bush Nicole R, Zhao Qi, Sathyanarayana Sheela, Paquette Alison G
Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, United States.
Department of Health Behavior and Nutrition Sciences, University of Delaware, Newark, DE, United States.
J Nutr. 2024 Dec;154(12):3603-3614. doi: 10.1016/j.tjnut.2024.10.019. Epub 2024 Oct 12.
Vitamin D is a hormone that regulates gene transcription. Prenatal vitamin D has been linked to immune and vascular function in the placenta, a key organ of pregnancy. Transcriptome-wide RNA sequencing can provide a more complete representation of the placental effects of vitamin D.
We investigated the association between prenatal vitamin D concentrations and placental gene expression in a large, prospective pregnancy cohort.
Participants were recruited from Shelby County, TN, United States, in the Conditions Affecting Neurocognitive Development and Learning in Early childhood (CANDLE) study. Vitamin D (plasma total 25-hydroxyvitatmin D, [25(OH)D]) was measured at midpregnancy (16-28 wk) and delivery. RNA was sequenced from placental samples collected at birth. We identified differentially expressed genes (DEGs) using adjusted linear regression models. We also conducted weighted gene coexpression network analysis.
The median 25(OH)D of participants was 21.8 ng/mL at midpregnancy (N = 774; IQR: 15.4-26.5 ng/mL) and 23.6 ng/mL at delivery (n = 753; IQR: 16.8-29.1 ng/mL). Placental expression of 17 DEGs was associated with 25(OH)D at midpregnancy, but only 1 DEG was associated with 25(OH)D at delivery. DEGs were related to energy metabolism, cytoskeletal function, and transcriptional regulation. We identified 2 weighted gene coexpression network analysis gene modules whose expression was associated with 25(OH)D at midpregnancy and 1 module associated with 25(OH)D at delivery. These modules were enriched for genes related to mitochondrial and cytoskeletal function and were regulated by transcription factors including ARNT2 and FOSL2. We also identified 12 modules associated with 25(OH)D in females and 1 module in males.
25(OH)D during midpregnancy, but not at delivery, is associated with placental gene expression at birth. Future research is needed to investigate a potential role of vitamin D in modulating placental mitochondrial metabolism, intracellular transport, and transcriptional regulation during pregnancy.
维生素D是一种调节基因转录的激素。孕期维生素D与胎盘(妊娠的关键器官)的免疫和血管功能有关。全转录组RNA测序能够更全面地呈现维生素D对胎盘的影响。
我们在一个大型前瞻性妊娠队列中研究了孕期维生素D浓度与胎盘基因表达之间的关联。
参与者来自美国田纳西州谢尔比县的儿童早期神经认知发育和学习影响因素(CANDLE)研究。在妊娠中期(16 - 28周)和分娩时测量维生素D(血浆总25 - 羟基维生素D,[25(OH)D])。对出生时采集的胎盘样本进行RNA测序。我们使用校正线性回归模型鉴定差异表达基因(DEG)。我们还进行了加权基因共表达网络分析。
参与者在妊娠中期的25(OH)D中位数为21.8 ng/mL(N = 774;四分位间距:15.4 - 26.5 ng/mL),分娩时为23.6 ng/mL(n = 753;四分位间距:16.8 - 29.1 ng/mL)。17个差异表达基因的胎盘表达在妊娠中期与25(OH)D相关,但在分娩时只有1个差异表达基因与25(OH)D相关。差异表达基因与能量代谢、细胞骨架功能和转录调控有关。我们鉴定出2个加权基因共表达网络分析基因模块,其表达在妊娠中期与25(OH)D相关,1个模块在分娩时与25(OH)D相关。这些模块富含与线粒体和细胞骨架功能相关的基因,并受包括芳香烃受体核转位蛋白2(ARNT2)和FOS样抗原2(FOSL2)在内的转录因子调控。我们还鉴定出12个在女性中与25(OH)D相关的模块和1个在男性中与25(OH)D相关的模块。
妊娠中期而非分娩时的25(OH)D与出生时的胎盘基因表达相关。未来需要开展研究,以调查维生素D在孕期调节胎盘线粒体代谢、细胞内运输和转录调控中的潜在作用。